Study Shows Sunlight May Affect Blood Vessels of Rosacea Patients
LOS ANGELES (September 23, 2002) -- Sun exposure appears to trigger a substance in the body that may lead to the visible blood vessels that often appear with rosacea, a conspicuous facial disorder now estimated to affect 14 million Americans, according to a study funded by the National Rosacea Society and reported at the annual meeting of the Society for Investigative Dermatology here.
"Our initial study showed that sunlight may indeed have a role in causing rosacea," said Dr. Marita Kosmadaki, research fellow, Department of Dermatology, Boston University, who presented results of her research with Dr. Mina Yaar, professor of dermatology at Boston University. Drs. Yaar and Kosmadaki found that exposure to ultraviolet (UV) radiation -- a component of sunlight -- led to the production of vascular endothelial growth factor (VEGF), a substance that has been linked to the development of visible blood vessels (telangiectasia).
"The melanin in the skin of darker-skinned individuals appears to make it difficult for UV radiation to reach the lower layers of the skin," Dr. Kosmadaki noted. "As a result, in darker-skinned individuals VEGF would tend to be induced only in the upper skin layers, and hence would not affect the blood vessels. In contrast, sufficient ultraviolet rays could induce VEGF synthesis in the deeper skin layers in fair-skinned individuals."
Because other researchers had found the production of VEGF can be triggered by another molecule called tumor necrosis factor (TNF), Drs. Yaar and Kosmadaki hypothesized that the UV radiation first induced the production of TNF, and its release in turn led to the synthesis of VEGF.
They then tested whether a hexapeptide, which binds TNF and cancels its effect, would block VEGF production and leave blood vessels unaffected. However, their research found that blocking this single pathway was ineffective in preventing the production of VEGF.
"Our findings have shed new light on the potential pathogenesis of this vascular component of rosacea," Dr. Kosmadaki said. "It appears that sun-induced VEGF may play a significant role in rosacea, and its production process seems to involve factors other than TNF. This opens the way for further research that may lead to substantial improvements in treatment or prevention."
In a recent survey of 1,066 rosacea patients by the National Rosacea Society, 81 percent reported that sun exposure aggravated their condition. People with rosacea are advised to protect their skin year round by wearing a sunscreen.
The National Rosacea Society has instituted a research grants program to encourage and support scientific investigation into the potential causes and other key aspects of this prevalent disorder. Because the etiology of rosacea is unknown, a high priority is given to funding research in such areas as its pathogenesis, progression, mechanism of action, cell biology and potential genetic factors.
For information and educational materials on rosacea, write the National Rosacea Society, 800 S. Northwest Highway, Suite 200, Barrington, Illinois 60010, or call its toll-free number at 1-888-NO-BLUSH. Information and materials are also available on the society's Web site at www.rosacea.org, or via e-mail at email@example.com.
196 James St.
Barrington, IL 60010
The National Rosacea Society is a 501(c)(3) nonprofit organization whose mission is to improve the lives of people with rosacea by raising awareness, providing public health information and supporting medical research on this widespread but little-known disorder. The information the Society provides should not be considered medical advice, nor is it intended to replace
consultation with a qualified physician. The Society does not evaluate, endorse or recommend any particular medications, products, equipment or treatments. Rosacea may vary substantially from one patient to another, and treatment must be tailored by a physician for each individual case. For more information, visit About Us.